National Path Lab
Women's Health & Reproductive Genetics

Recurrent Pregnancy Loss

Recurrent pregnancy loss refers to repeated pregnancy losses and may have multiple possible causes, including chromosomal abnormalities, anatomical factors, endocrine or metabolic conditions, autoimmune disorders, thrombophilia-related conditions, and other causes.

Laboratory and genetic investigations may help identify selected underlying factors, allowing your doctor to recommend appropriate management for future pregnancies where a cause is identified.

At National Path Lab (NPL), specialized investigations support the evaluation of couples experiencing recurrent pregnancy loss.

Tests available
9
Tests available
Health package
1
Health package

Tests Available at NPL

GLUCOSE FASTING

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 50

GLYCOSYLATED HEMOGLOBIN; HBA1C

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

ANTI BETA 2 GLYCOPROTEIN 1; B2GP1, IGG

Turn Around Time
SAMPLE BY SUN & WED 1:00 PM REPORT ON SAME DAY LATE EVENING

Rs. 2500

ANTI BETA 2 GLYCOPROTEIN 1; B2GP1, IGM

Turn Around Time
SAMPLE BY SUN & WED 1:00 PM REPORT ON SAME DAY LATE EVENING

Rs. 2500

ANTI CARDIOLIPIN ANTIBODY IGG

Turn Around Time
SAMPLE BY SUN & WED 1:00 PM REPORT ON SAME DAY LATE EVENING

Rs. 1800

LUPUS ANTICOAGULANT BY DRVVT

Turn Around Time
SAMPLE DAILY BY 4:00 PM REPORT AFTER 3 DAYS

Rs. 3000

ANTI CARDIOLIPIN ANTIBODY IGM

Turn Around Time
SAMPLE BY SUN & WED 1:00 PM REPORT ON SAME DAY LATE EVENING

Rs. 1800

CHROMOSOME ANALYSIS (KARYOTYPE), BLOOD

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT AFTER 15 DAYS

Rs. 6500

THYROID PROFILE FREE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

About Recurrent Pregnancy Loss

Causes & Risk Factors

Recurrent pregnancy loss can arise from several distinct categories of underlying cause, often requiring a structured, stepwise evaluation:

•  Chromosomal abnormalities — in either parent, or arising sporadically in the pregnancy itself, are among the most common identifiable causes.

•  Antiphospholipid syndrome (APS) — an autoimmune clotting disorder associated with pregnancy loss, particularly after the first trimester.

•  Endocrine and metabolic conditions — thyroid dysfunction and poorly controlled blood glucose can both contribute to pregnancy loss risk.

•  Anatomical factors — uterine structural abnormalities can affect the ability to carry a pregnancy to term.

•  Thrombophilia-related conditions — inherited or acquired clotting tendencies may play a role in selected cases.

•  Age — the risk of pregnancy loss, largely related to chromosomal factors, increases with advancing maternal age.

Symptoms & When to Test

Recurrent pregnancy loss is defined by the pattern of pregnancy outcomes rather than symptoms during a single pregnancy.

•  Two or more consecutive pregnancy losses

•  Pregnancy losses occurring at a similar gestational stage across multiple pregnancies

•  Pregnancy loss after the first trimester, which may raise suspicion for antiphospholipid syndrome

•  Known thyroid disorder, diabetes, or autoimmune condition with recurrent pregnancy loss

When Should You Consider Testing?

Evaluation is generally recommended after two consecutive pregnancy losses, or sooner if there is a known risk factor such as advanced maternal age, a prior late pregnancy loss, or a known autoimmune or endocrine condition.

Why Tests Are Combined

Because recurrent pregnancy loss can stem from chromosomal, autoimmune, endocrine, or anatomical causes, a single test cannot rule in or rule out all possibilities — parental karyotyping addresses genetic causes, while the antiphospholipid antibody panel addresses autoimmune clotting risk, and these operate through entirely different mechanisms.

Thyroid and metabolic testing (TSH, free T4, HbA1c) is included because both hypothyroidism and poorly controlled glucose are treatable contributors to pregnancy loss risk, making them worthwhile to screen even when not clinically obvious.

In selected cases, genetic testing of the pregnancy tissue itself (products of conception) can clarify whether a specific loss was due to a chromosomal abnormality in that pregnancy — distinct from testing the parents — and the choice between these approaches depends on clinical history and the treating specialist's advice.

Tests Available at NPL

Test Code

Test

Clinical Relevance

Q0001

 

Parental Karyotyping

Chromosomal analysis of both partners, considered when a chromosomal rearrangement is suspected as a possible contributor to recurrent pregnancy loss.

H0014

 

Lupus Anticoagulant

Part of antiphospholipid antibody testing, considered when antiphospholipid syndrome is clinically suspected.

I0019 & I0020

 

Anticardiolipin Antibodies

Part of antiphospholipid antibody testing; may be assessed for IgG and/or IgM.

I0124 & I0125

 

Anti-β2 Glycoprotein I Antibodies

Another component of antiphospholipid antibody testing, often assessed alongside the above.

P0016

 

TSH & Free T4

Thyroid function assessment, since thyroid dysfunction is a treatable contributor to pregnancy loss risk.

H0020

 

HbA1c

Metabolic assessment where clinically appropriate, given the association between poor glucose control and pregnancy loss.

B0038

 

Glucose

 

Most reproductive hormone and genetic tests do not require fasting. However, some tests have specific timing requirements (such as a particular day of the menstrual cycle), and if other tests are ordered at the same time, fasting may be required for those investigations. Please follow the preparation and timing instructions provided by your doctor or NPL.

Home Sample Collection

NPL offers convenient home sample collection for Recurrent Pregnancy Loss blood tests, so you don't need to visit a lab in person.

→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.

→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.

→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2022 laboratory for processing.

→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.

When to See a Doctor

•  Two or more consecutive pregnancy losses

•  Pregnancy loss occurring after the first trimester

•  Known autoimmune, thyroid, or metabolic condition with recurrent pregnancy loss

•  Family history of recurrent pregnancy loss or known genetic condition

•  Planning a future pregnancy after prior loss(es)

Medical Disclaimer

Laboratory and genetic tests support the evaluation of recurrent pregnancy loss but do not identify a cause in every case. Results should be interpreted by a qualified specialist together with reproductive history and, where relevant, genetic counselling.

Related Packages

THALASSEMIA PROFILE

Test Includes
3 Tests

Rs. 4000

Frequently Asked Questions

Evaluation is generally considered after two consecutive pregnancy losses, though your doctor may recommend earlier testing based on individual risk factors or the gestational stage of the loss.
No. Testing the pregnancy tissue (products of conception) looks for a chromosomal abnormality in that specific pregnancy, while parental karyotyping looks for a chromosomal rearrangement carried by a parent that could affect future pregnancies. Both may be relevant depending on the clinical situation.
Most tests, including karyotyping and antiphospholipid antibodies, do not require fasting. If HbA1c or glucose testing is included, follow the specific preparation instructions provided.
No. Despite thorough evaluation, a specific cause is not identified in a significant proportion of cases. This does not necessarily indicate a poor prognosis for future pregnancies, and your doctor can discuss appropriate next steps.
Yes, with appropriate medical management under specialist care, many patients with confirmed antiphospholipid syndrome go on to have successful pregnancies.